U.S.: Do Not Mix Merck Hepatitis Pill With HIV Drugs
April 30, 2012
The Food and Drug Administration (FDA) said Thursday it is changing the label for Merck & Co.'s hepatitis C virus (HCV) treatment Victrelis following studies indicating it should not be taken with some common HIV drugs.
Updated Information on Drug Interactions Between Victrelis (Boceprevir) and Certain Boosted HIV Protease Inhibitor Drugs
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)